← Open Payments lookup

ERUM QAZI: Open Payments

NPI 1043625932 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,449 in 65 payments from 17 companies in 2025. Trend: 2023 $1,245 · 2024 $1,200 · 2025 $1,449

Food & beverage: $1,449
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$257
Neurocrine BioSciences, Inc.5$194
Axsome Therapeutics, Inc.12$186
ABBVIE INC.7$185
Almatica Pharma LLC7$113
Lundbeck LLC4$93
Teva Pharmaceuticals USA, Inc.4$85
Janssen Pharmaceuticals, Inc3$56
Alkermes, Inc.3$55
KVK-Tech, Inc.1$52

Products named: REXULTI, INGREZZA, Auvelity, VRAYLAR, LOREEV XR, AUSTEDO XR, SPRAVATO, ARISTADA.

Industry payments across MO — which companies pay providers there.